Gene clusters-based pathway enrichment analysis identifies four pan-cancer subtypes with distinct molecular and clinical features
- Mengli Xu 1,2,3, Hongjing Ai 1,2,3, Danni Wang 1,2,3, Xiaosheng Wang 4,5,6
- Mengli Xu 1,2,3, Hongjing Ai 1,2,3, Danni Wang 1,2,3
- 1Biomedical Informatics Research Lab, School of Basic Medicine and Clinical Pharmacy, Pharmaceutical University, 211198, Nanjing, China.
- 2Institute of Innovative Drug Discovery and Development, China Pharmaceutical University, 211198, Nanjing, China.
- 3Big Data Research Institute, China Pharmaceutical University, 211198, Nanjing, China.
- 4Biomedical Informatics Research Lab, School of Basic Medicine and Clinical Pharmacy, Pharmaceutical University, 211198, Nanjing, China. xiaosheng.wang@cpu.edu.cn.
- 5Institute of Innovative Drug Discovery and Development, China Pharmaceutical University, 211198, Nanjing, China. xiaosheng.wang@cpu.edu.cn.
- 6Big Data Research Institute, China Pharmaceutical University, 211198, Nanjing, China. xiaosheng.wang@cpu.edu.cn.
- 0Biomedical Informatics Research Lab, School of Basic Medicine and Clinical Pharmacy, Pharmaceutical University, 211198, Nanjing, China.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.A new algorithm, PathClustNet, identifies four distinct cancer subtypes based on pathway activity. These subtypes show varied clinical and molecular features, paving the way for precision oncology treatments.
Area Of Science
- Oncology
- Bioinformatics
- Computational Biology
Background
- Tumor heterogeneity poses challenges in cancer research and treatment.
- Existing pathway-based clustering methods require pre-defined pathways, limiting their scope.
- Identifying distinct cancer subtypes is crucial for developing targeted therapies.
Purpose Of The Study
- To develop and validate a novel algorithm, PathClustNet, for pathway-based cancer subtype identification.
- To explore tumor heterogeneity using a data-driven approach without pre-specified pathways.
- To uncover novel pan-cancer subtypes with distinct molecular and clinical characteristics.
Main Methods
- Developed the PathClustNet algorithm for unsupervised pathway-based clustering.
- Applied PathClustNet to The Cancer Genome Atlas (TCGA) pan-cancer dataset.
- Identified gene clusters, associated overrepresented pathways, and calculated pathway enrichment scores for clustering.
Main Results
- Identified four distinct pan-cancer subtypes (C1-C4) based on pathway enrichment.
- Characterized subtypes by metabolic activity, immune/developmental/stromal activity, cell cycle/DNA repair activity, and neuronal pathway activity.
- Subtypes exhibited differential TP53 mutation rates, tumor purity, genomic stability, and chemotherapy response.
- Discovered correlations between clinical factors (age, smoking, infections, alcohol) and pathway activities.
Conclusions
- PathClustNet provides a novel, unsupervised method for classifying pan-cancer subtypes.
- The identified subtypes (C1-C4) represent distinct molecular and clinical entities.
- These findings support the potential of pathway-based classification for advancing precision oncology.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
02:26
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
01:19
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...

